Live feed
Filing
SC 13G/A
SC 13G/A0001213900-20-017520·Innovation Pharmaceuticals Inc.
Schedule 13G ownership disclosure
CELLCEUTIX CORP COM
Security class unavailable · CUSIP: 15115V101
Event date: 2020-07-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-017520
- Form type
- SC 13G/A
- Filer
- Innovation Pharmaceuticals Inc.
- CIK
- CIK 1355250
- Filed
- Jul 15, 2020
- Reporting period
- Jul 13, 2020
- Description
- Schedule 13G beneficial ownership